Revenues Working Against Elutia Inc.’s (NASDAQ:ELUT) Share Price
With a price-to-sales (or “P/S”) ratio of 3.1x Elutia Inc. (NASDAQ:ELUT) may be sending very bullish signals at the moment, given that almost half of all the Biotechs companies in the United States have P/S ratios greater than 8x and even P/S higher than 52x are not unusual. Although, it’s not wise to just take the P/S at face value as there may be an explanation why it’s so limited.
View our latest analysis for Elutia
How Elutia Has Been Performing
Elutia hasn’t been tracking well recently as its declining revenue compares poorly to other companies,…
